Aurora Cannabis (ACB) Gets a Hold Rating from BMO Capital


Aurora Cannabis (ACB), the Healthcare company was revisited today, yet the Wall Street analyst remains currently on the sidelines. Analyst Tamy Chen from BMO Capital rated Aurora Cannabis (ACB) a Hold, setting a C$12 price target.

According to TipRanks.com, Chen is a 5-star analyst with an average return of 45.7% and a 100.0% success rate. Chen covers the Healthcare sector, focusing on stocks such as CannTrust Holdings Inc, Aurora Cannabis Inc, and Tilray Inc.

Aurora Cannabis has an analyst consensus of Strong Buy, with a price target consensus of C$14.33.

Aurora Cannabis’ market cap is currently C$11.65B and has a P/E ratio of 1167. The company has a Price to Book ratio of 2.71.

Aurora Cannabis, Inc. is a Canada-based company, which is engaged in the production and distribution of medical cannabis. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

The company’s shares closed on Thursday at C$11.74.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts